Study
|
No IRS
|
IRS
|
Crude IRR
|
(95% Conf. Interval)
|
---|
Month
|
RDT +
|
Cohort months at risk
|
Cumulative cases
|
RDT +
|
Cohort months at risk
|
Cumulative cases
|
---|
1
|
398
| |
398
|
380
| |
380
| | |
2
|
374
|
600
|
772
|
422
|
705
|
802
|
0.96
|
(0.83, 1.11)
|
3
|
406
|
812
|
1178
|
353
|
767
|
1155
|
0.92
|
(0.80, 1.06)
|
4
|
345
|
644
|
1523
|
234
|
602
|
1389
|
0.73
|
(0.61, 0.86)
|
5
|
393
|
759
|
1916
|
331
|
762
|
1720
|
0.84
|
(0.72, 0.97)
|
6
|
355
|
678
|
2271
|
282
|
657
|
2002
|
0.82
|
(0.70, 0.96)
|
7
|
301
|
653
|
2572
|
282
|
692
|
2284
|
0.88
|
(0.75, 1.04)
|
8
|
227
|
663
|
2799
|
199
|
700
|
2483
|
0.83
|
(0.68, 1.01)
|
9
|
207
|
590
|
3006
|
163
|
628
|
2646
|
0.74
|
(0.60, 0.91)
|
10
|
209
|
724
|
3215
|
167
|
721
|
2813
|
0.80
|
(0.65, 0.99)
|
11
|
146
|
725
|
3361
|
137
|
747
|
2950
|
0.91
|
(0.72, 1.16)
|
12
|
154
|
698
|
3515
|
88
|
681
|
3038
|
0.59
|
(0.45, 0.77)
|
13
|
242
|
678
|
3757
|
172
|
693
|
3210
|
0.70
|
(0.57, 0.85)
|
14
|
233
|
619
|
3990
|
162
|
644
|
3372
|
0.67
|
(0.54, 0.82)
|
15
|
239
|
612
|
4229
|
204
|
633
|
3576
|
0.83
|
(0.68, 1.00)
|
16
|
326
|
688
|
4555
|
258
|
666
|
3834
|
0.82
|
(0.69, 0.96)
|
17
|
319
|
672
|
4874
|
265
|
675
|
4099
|
0.83
|
(0.70, 0.98)
|
18
|
260
|
632
|
5134
|
242
|
640
|
4341
|
0.92
|
(0.77, 1.10)
|
19
|
225
|
654
|
5359
|
160
|
653
|
4501
|
0.71
|
(0.58, 0.88)
|
20
|
187
|
655
|
5546
|
118
|
651
|
4619
|
0.63
|
(0.50, 0.80)
|
21
|
197
|
610
|
5743
|
170
|
574
|
4789
|
0.92
|
(0.74, 1.13)
|
22
|
15
|
37
|
5758
|
12
|
101
|
4801
|
0.30
|
(0.13, 0.68)
|
- IRSindoor residual spraying, RDT rapid diagnostic test, IRR incidence rate ratio